Key statistics
On Wednesday, Hydreight Technologies Inc (NURS:CVE) closed at 0.265, 32.50% above the 52 week low of 0.20 set on Apr 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.295 |
---|---|
High | 0.295 |
Low | 0.255 |
Bid | -- |
Offer | -- |
Previous close | 0.29 |
Average volume | 9.83k |
---|---|
Shares outstanding | 40.32m |
Free float | 14.15m |
P/E (TTM) | -- |
Market cap | 11.69m CAD |
EPS (TTM) | -0.0556 CAD |
Data delayed at least 15 minutes, as of Aug 14 2024 19:57 BST.
More ▼
- Hydreight Expands Its “At-Home Blood Testing” Solution with More Tests to All 50 States
- Hydreight Provides Corporate Update Reflecting Significant Revenue Growth and Strong Organic Operational Growth
- Hydreight Adds The Third National Wellness Medspa Franchise for White Label Solution
- Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That Helps Companies Launch A D2C Healthcare Brand In All 50 States
- Hydreight Reports Record Topline(1) Revenue of $4.87M in Q1-2024 (YOY Increase of 33%)
- Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 Medications (Low-Cost Semaglutide), NAD+ and more
- Hydreight Achieves Record Revenue, Files Audited Financial Statements for Fiscal Year 2023
- Hydreight Partners with American Frontline Nurses with a Network of Over 26,000 Nurses
- Hydreight Partners with Ola Digital Health, an Independent, National Pharmacy Network to Provide Health and Wellness Services in Store
- Hydreight Founder and CEO, Shane Madden, Joins Founding Member Board of the American IV Association
More ▼